Purpose: To further assess the construct validity of ICOAP, a new osteoarthritis (OA) pain measure. Methods: The new measure, ICOAP, is comprised of 5 items assessing 'constant' hip or knee pain and 6 items assessing 'intermittent' hip or knee pain; item response options are on a 4-point scale from 'not at all' to 'extremely'. Subscale and total scores are standardized to 0 to 100, where higher scores indicate worse pain. The ICOAP was administered by phone to an established community cohort aged 55+ years with moderate to severe hip and/or knee OA. All subjects completed both the hip and knee versions of the ICOAP, regardless of which joints were painful at the time. Participants also completed other measures of arthritis pain and disability (WOMAC pain, function and stiffness subscales; McGill pain intensity scale, and the limitation dimension of the Late Life Function and Disability Instrument), the Profile of Mood States-Brief (POMS) fatigue/inertia scale, the SF-36 general health perception scale, the CES-D scale for depressed mood, the Lubben Social Network Scale, and the Pain Catastrophizing Scale. Summary descriptive statistics were calculated for all scale scores. Spearman's rho correlation coefficients were calculated to assess the relationship between ICOAP Hip and Knee subscale and total scores with each of the other measures. T-tests were used to compare means ICOAP scores for men versus women. Results: The mean age of the 659 participants was 77.6 years (58.7 to 97.9), 77.4% were female and 23.7% had < high school education; 631 had complete data for ICOAP Hip and 608 for ICOAP Knee. Mean score (SD) for the hip was 26.8 (SD 25.0) and 18.0 (SD 26.8) for intermittent and constant pain, respectively. For the knee, mean intermittent and constant pain scores were 30.9 (SD 23.3) and 16.0 (SD 26.5), respectively. Women had higher intermittent and total ICOAP pain scores than men (hip and knee results similar, p < 0.05 for all). Within individuals, intermittent and constant pain scores were only modestly correlated (r = 0.29 for the knee; r = 0.46 for the hip, p < 0.0001 for both) and their strength of association with other measures differed (e.g. correlation with pain catastrophizing score: intermittent pain r = 0.27 versus constant pain r = 0.39). For the hip, measures of coping, fatigue, mood and physical functioning were more strongly related to constant than to intermittent pain. For the knee, the reverse was generally true, with stronger correlations being associated with intermittent knee pain scores. ICOAP score correlations with WOMAC pain scores ranged from 0.39 (hips; ICOAP intermittent pain) to 0.65 (knees; ICOAP total pain). Higher scores for both intermittent and constant pain were associated with lower general health status, higher scores on other pain and disability measures, higher scores for depression, fatigue and pain catastrophizing, and lower scores for social support. Conclusions: Our results provide further evidence of the ICOAP as a valid tool for evaluation of pain in hip and knee OA and supports use of the two subscale scores for intermittent and constant pain independently as distinct and important domains of OA pain. 
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Purpose: Four previous studies (n = 1675) have shown that C-Reactive Protein (CRP) levels are associated with (progression of) knee osteoarthritis (KOA). At this moment, there are only three studies (n = 968) published, examining the relationship between CRP levels and joint complaints or disability. In this population-based study, we analyzed the association between CRP levels and KOA-related knee pain and the relationship between CRP levels, body mass index (BMI) and KOA since it is still not clear whether BMI plays a role as a confounder or as effect mediator in this model. Methods: In total, 1655 women from the Rotterdam Study had data on radiographic knee OA, age, BMI and CRP levels. High-sensitivity CRP measurements were performed using rate near-infrared particle immunoassay. For all statistical analysis, log-transformed CRP values were used. KOA was defined as a Kellgren/Lawrence score 2 in one or both knees. Knee pain was defined as having pain in the right or left knee during the last month or the past five years. Results: Women with knee OA had 30% higher CRP levels compared to women without KOA (p = 8×10 −7 ), but after adjustment for age and BMI this association disappeared (p = 0.3). We next stratified our data according to BMI, to investigate the role of BMI as an effect modifier. We observed that women with a BMI < 27.0 kg/m 2 and with KOA had 34% higher levels of CRP compared to women without KOA (p = 0.004 after adjustment for age and co-morbidity). Importantly, this association was absent in women with a BMI > 27.0 kg/m 2 (p = 0.63). CRP levels were borderline significant associated with an increased risk of knee pain in our study (p = 0.053 after adjustment for age and BMI). This effect was only visible in women with radiographic KOA (27% higher CRP levels, p = 0.03 after adjustment for age and BMI) and not in women without KOA (p = 0.43).
